All lobbying filings

HB STRATEGIES

HB STRATEGIES filed a Q4 report for BAYER U.S. LLC on January 19, 2026, reporting $120,000 in lobbying income.

Lobbying for BAYER U.S. LLC · Pharmaceutical and life sciences company

All filings by HB STRATEGIES · Everything BAYER U.S. LLC has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 19, 2026

Income

$120,000

What the client paid this registrant for the period.

Client based in

New Jersey

Official filing document

Lobbyists on this filing 2

GREGG HARTLEY

Previously held: Congressman Blunt - Chief of Staff
ERIC LAUSTEN

Previously held: Congressman Lipinski - Chief of Staff, Assistant House Science, Space &Technology Committee - Legislative Director Congressman Acevedo-Vila- Legislative Director Congressmen McKinney - Legislative Director

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Health Issues

Provide lobbying support on key issues and track relevant federal policy developments that could impact the pharmaceutical, healthcare industries generally and Bayer specifically.

Agriculture

Provide lobbying support on key issues and track relevant federal policy developments that could impact the pharmaceutical, healthcare industries generally and Bayer specifically.

Pharmacy

Provide lobbying support on key issues and track relevant federal policy developments that could impact the pharmaceutical, healthcare industries generally and Bayer specifically.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.